# The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression

> **NCT02037503** · PHASE3 · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Suicidal Ideation
- Major Depressive Disorder
- Healthy Participants

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT02037503
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2020-05
- **Final completion:** 2020-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037503, "The Effect of Ketamine on Mechanises Underlying Suicidal Ideation and Drug-resistant Major Depression". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02037503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*